| Dr Karekin R Cunningham, MD | |
|
770 Pine St, Suite 290, Macon, GA 31201-2173 | |
| (478) 743-1458 | |
| Not Available |
| Full Name | Dr Karekin R Cunningham |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 770 Pine St, Macon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316162779 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 060822 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
| Coliseum Northside Hospital | Macon, GA | Hospital |
| Medical Center, Navicent Health (the) | Macon, GA | Hospital |
| Medical Center Of Peach County, Navicent Health | Byron, GA | Hospital |
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Georgia Mri Llc | 5597752261 | 35 |
| Radiology Associates Of Macon Pc | 7113817701 | 67 |
News Archive
The explosion and fire on a BP-licensed oil platform in the Gulf of Mexico in April 2010 had huge environmental and economic effects, with millions of gallons of oil leaking into the water for more than five months. It also had significant psychological impact on people living in coastal communities, even in those areas that did not have direct oil exposure, according to researchers at the University of Maryland School of Medicine who worked in collaboration with the University of Florida, Gainesville.
Governments in Eastern Europe have been forced to restructure their growth strategies and focus on attracting investors outside of the European Union in response to the Eurozone crisis.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 6 days ago
| Entity Name | Radiology Associates Of Macon Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679563035 PECOS PAC ID: 7113817701 Enrollment ID: O20040317001131 |
News Archive
The explosion and fire on a BP-licensed oil platform in the Gulf of Mexico in April 2010 had huge environmental and economic effects, with millions of gallons of oil leaking into the water for more than five months. It also had significant psychological impact on people living in coastal communities, even in those areas that did not have direct oil exposure, according to researchers at the University of Maryland School of Medicine who worked in collaboration with the University of Florida, Gainesville.
Governments in Eastern Europe have been forced to restructure their growth strategies and focus on attracting investors outside of the European Union in response to the Eurozone crisis.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 6 days ago
| Entity Name | Georgia Magnetic Imaging Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114900545 PECOS PAC ID: 0042205775 Enrollment ID: O20040420000779 |
News Archive
The explosion and fire on a BP-licensed oil platform in the Gulf of Mexico in April 2010 had huge environmental and economic effects, with millions of gallons of oil leaking into the water for more than five months. It also had significant psychological impact on people living in coastal communities, even in those areas that did not have direct oil exposure, according to researchers at the University of Maryland School of Medicine who worked in collaboration with the University of Florida, Gainesville.
Governments in Eastern Europe have been forced to restructure their growth strategies and focus on attracting investors outside of the European Union in response to the Eurozone crisis.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 6 days ago
| Entity Name | Central Georgia Mri Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114908522 PECOS PAC ID: 5597752261 Enrollment ID: O20040427000147 |
News Archive
The explosion and fire on a BP-licensed oil platform in the Gulf of Mexico in April 2010 had huge environmental and economic effects, with millions of gallons of oil leaking into the water for more than five months. It also had significant psychological impact on people living in coastal communities, even in those areas that did not have direct oil exposure, according to researchers at the University of Maryland School of Medicine who worked in collaboration with the University of Florida, Gainesville.
Governments in Eastern Europe have been forced to restructure their growth strategies and focus on attracting investors outside of the European Union in response to the Eurozone crisis.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karekin R Cunningham, MD 770 Pine St, Suite 290, Macon, GA 31201-2173 Ph: (478) 743-1458 | Dr Karekin R Cunningham, MD 770 Pine St, Suite 290, Macon, GA 31201-2173 Ph: (478) 743-1458 |
News Archive
The explosion and fire on a BP-licensed oil platform in the Gulf of Mexico in April 2010 had huge environmental and economic effects, with millions of gallons of oil leaking into the water for more than five months. It also had significant psychological impact on people living in coastal communities, even in those areas that did not have direct oil exposure, according to researchers at the University of Maryland School of Medicine who worked in collaboration with the University of Florida, Gainesville.
Governments in Eastern Europe have been forced to restructure their growth strategies and focus on attracting investors outside of the European Union in response to the Eurozone crisis.
Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 6 days ago
Paul Winston Chandler, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 770 Pine St Ste 290, Attn: Radiology Department, Macon, GA 31201 Phone: 478-743-1458 Fax: 478-755-1332 | |
Bradley Alan Ebel, DO Radiology Medicare: May Accept Medicare Assignments Practice Location: 770 Pine St Ste 290, Attn: Radiology Department, Macon, GA 31201 Phone: 478-743-1458 Fax: 478-755-1332 | |
Murray Charles Relf, MD Radiology Medicare: Medicare Enrolled Practice Location: 770 Pine St Ste 290, Attn: Radiology Department, Macon, GA 31201 Phone: 478-743-1458 Fax: 478-755-1332 | |
Kazumi Chino, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 800 1st St Ste 110, Macon, GA 31201 Phone: 478-743-3466 Fax: 478-746-2049 | |
Thomas Franklin Glass Iii, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 770 Pine St Ste 290, Attn: Radiology Department, Macon, GA 31201 Phone: 478-743-1458 Fax: 478-755-1332 | |
Mark Edward Barrow, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 770 Pine Street, Suite 290, Macon, GA 31201 Phone: 478-751-5825 Fax: 478-755-1332 | |
Alan D Kirsh, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 770 Pine St, Suite 290, Macon, GA 31201 Phone: 478-743-0029 |